The findings of the study, funded by the British Rosetrees Trust, and published recently in the journal Aging Cell, reinforces the claim that blocking the signaling pathway of insulin and the growth hormone IGF1, a pathway known to be a central controller of the aging process in worms and mammals, can potentially be used as a treatment for degenerative brain diseases, said the researchers, led by Dr. Ehud Cohen of Hebrew University’s Faculty of Medicine. The new findings are the first evidence that a pharmacological substance can effectively protect against toxicity of proteins associated with neurodegenerative diseases, through selective inhibition of the aging process, they said. The researchers have registered a patent for their discovery.
- Vaccine Education Summit
- Bitcoin Summit
- Ernie's Favorites
- THE R3VOLUTION CONTINUES
- "It's Not My Debt"
- Fascist Nation's Favorites
- Surviving the Greatest Depression
- The Only Solution - Direct Action Revolution
- Western Libertarian
- S.A.F.E. - Second Amendment is For Everyone
- Freedom Summit
- Declare Your Independence
- FreedomsPhoenix Speakers Bureau
- Wallet Voting
- Harhea Phoenix
- Black Market Friday
According to the Hebrew University researchers, who tested the new material on worms, this is the first substance that shows potential to treat or prevent diseases like Alzheimer’s, Parkinson’s and Huntington’s.
Additional Related items you might find interesting:Related items:
News Link • Healthcare
News Link • United Kingdom
News Link • Mexico
News Link • Robots and Artificial Intelligence